Therefore, determining the exact role of YAP1 in FA-HNSCC may require additional analysis through further genetic targeting of YAP1, further analysis of drug response using other available inhibitors, and in vivo studies. Here, YAP1 is linked to head and neck squamous cell carcinoma.